The decisions that determine Phase 2 timing are made, or missed, in the first two quarters after the IND opens.
White Paper
IND Ready Is Not Phase 2 Ready
Related Resources
All Resources
case-study
Driving Operational Excellence: Optimizing a Quality Management System for a State-of-the-Art Biomanufacturing Facility
Read More
post
A CMC Consultant’s Critical Role in Successful Regulatory Submissions
Read More
post
How CMC Consulting Accelerates Product Development Timelines
Read More
post
CMC Manufacturing and Its Impact on FDA Approvals
Read More
Let's move from science to success.
Let’s Talk